What is the name of the drug-coated balloon (DCB) coating?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Practice for Clinical Training 1 (CT1) Day 4 Exam. Enhance your skills with a range of questions designed to test your clinical knowledge. Each question features detailed explanations to help you succeed.

Multiple Choice

What is the name of the drug-coated balloon (DCB) coating?

Explanation:
The drug-coated balloon (DCB) coating is typically associated with paclitaxel, which is a chemotherapy medication that inhibits cell division and is used in various drug-eluting devices to prevent restenosis after angioplasty procedures. The role of paclitaxel in DCBs is crucial because it helps to deliver the drug directly to the vessel wall, thereby reducing the proliferation of smooth muscle cells that can lead to narrowing of the artery again. The name "TransPax" refers specifically to a type of drug delivery system used in DCBs, but it is not a standard name for the coating itself, which is primarily identified with paclitaxel. Therefore, recognizing paclitaxel as the active coating drug explains its prominent application in this context. Hence, understanding the role of paclitaxel can greatly inform on how DCBs function therapeutically.

The drug-coated balloon (DCB) coating is typically associated with paclitaxel, which is a chemotherapy medication that inhibits cell division and is used in various drug-eluting devices to prevent restenosis after angioplasty procedures. The role of paclitaxel in DCBs is crucial because it helps to deliver the drug directly to the vessel wall, thereby reducing the proliferation of smooth muscle cells that can lead to narrowing of the artery again.

The name "TransPax" refers specifically to a type of drug delivery system used in DCBs, but it is not a standard name for the coating itself, which is primarily identified with paclitaxel. Therefore, recognizing paclitaxel as the active coating drug explains its prominent application in this context. Hence, understanding the role of paclitaxel can greatly inform on how DCBs function therapeutically.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy